Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy

NCT01663753 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Cancer of the Uterine Cervix

Interventions

DEVICE: 18F-FDG-PET

Sponsor

Hospices Civils de Lyon